Key points are not available for this paper at this time.
PURPOSE: This study examined whether older age moderates the association between gender-affirming medical treatment and quality of life (QOL) among transgender individuals. METHODS: Transgender men and women from the National Transgender Discrimination Survey who had either recently or never undergone medical treatment were included (n = 2420). A moderation analysis was utilized. RESULTS: As predicted, participants who initiated medical treatment had higher QOL than those who did not. Age moderated this association. The QOL difference was greater for older than for younger transgender individuals. CONCLUSION: Among all transgender men and women, gender-affirming medical treatment can be especially beneficial for elders.
Cai et al. (Tue,) studied this question.